Company profile
UK company 08432406, incorporated on 6 March 2013.
Ph Therapeutics Limited is a UK company with status Active founded in 2013.
Company number 08432406
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
PH Therapeutics is developing antibody therapies to treat Pulmonary Arterial Hypertension.
PH Therapeutics Ltd is a new business that intends to develop novel antibody therapies to treat the orphan disease Pulmonary Arterial Hypertension (PAH). The goal is to develop these new therapies to the clinic and to bring benefit to patients suffering from this rare and debilitating disease.
Through the work of Dr Allan Lawrie at the University of Sheffield, PH Therapeutics is developing novel antibody therapies that aim to reverse the progression of pulmonary arterial hypertension leading to improved treatments for patients.
Background IP related to a therapeutic target
